杭州高田生物医药

Gaotian Biotech is a clinical-stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the development of high-end complex injections and innovative drug delivery systems. The company utilizes its proprietary lipid-based technology platforms, including liposomes and lipid nanoparticles (LNPs), to improve the therapeutic index of both small molecules and nucleic acid drugs. Its lead programs target significant unmet needs in oncology and anesthesia, with several candidates currently in clinical trials. By integrating formulation expertise with clinical development, Gaotian Biotech strives to provide more effective and safer treatment options for patients globally. The company's portfolio includes improved versions of established chemotherapeutics and novel mRNA-LNP therapeutics.